WMA Declaration of Helsinki – Ethical Principles f... ...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Drug candidate slows motor neuron disease progress...
Connecticut doctors are part of new cancer trials: The goal?...
December 22,2025
The FDA removes a long-standing warning from hormone-based m...
December 21,2025
Can colostrum supplements improve your skin, gut and immune ...
December 20,2025
Common heartburn and blood pressure medicines linked to adve...
December 19,2025
New medication reduced high triglyceride levels, improved ch...
December 18,2025
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Q & A
Wellness
Traditional medicine
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Announcement of the 2025 Nobel Prize in ...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Chaperone-mediated autophagy prevents loss of brown adipose tissue activity during aging

Chaperone-mediated autophagy prevents loss of brown adipose tissue activity during aging

byUniversity of BarcelonaUnaltered morphology of differentiated brown adipocytes with targeted knockdown of Lamp2A (L2A-KD). Representative micrographs of differentiated brown adipocytes transduced wi
Geriatrics December 28,2025
Chaperone-mediated autophagy prevents loss of brown adipose tissue activity during aging

Chaperone-mediated autophagy prevents loss of brown adipose tissue activity during aging

byUniversity of BarcelonaUnaltered morphology of differentiated brown adipocytes with targeted knockdown of Lamp2A (L2A-KD). Representative micrographs of differentiated brown adipocytes transduced wi
Geriatrics December 28,2025
Ret finger protein: A hidden molecular switch that fuels obesity

Ret finger protein: A hidden molecular switch that fuels obesity

by Chonnam National UniversityResearchers identify RFP as a fundamental molecule that plays a critical role in fat cell generation and affects the storage of fat within the adipose tissues, highlighti
Nutrition December 28,2025
Ret finger protein: A hidden molecular switch that fuels obesity

Ret finger protein: A hidden molecular switch that fuels obesity

by Chonnam National UniversityResearchers identify RFP as a fundamental molecule that plays a critical role in fat cell generation and affects the storage of fat within the adipose tissues, highlighti
Nutrition December 28,2025
New ALS diagnostic blood test boasts 97% accuracy

New ALS diagnostic blood test boasts 97% accuracy

by Brain Chemistry LabsDr. Rachael Dunlop using qPCR to sequence miRNA for an ALS blood test at the Brain Chemistry Labs in Jackson Hole. Credit: Paul Alan CoxALS is a debilitating paralytic disease c
Neurology December 28,2025
New ALS diagnostic blood test boasts 97% accuracy

New ALS diagnostic blood test boasts 97% accuracy

by Brain Chemistry LabsDr. Rachael Dunlop using qPCR to sequence miRNA for an ALS blood test at the Brain Chemistry Labs in Jackson Hole. Credit: Paul Alan CoxALS is a debilitating paralytic disease c
Neurology December 28,2025
AI chatbots often outperform doctors in diagnosis, but need safeguards to avoid overprescribing

AI chatbots often outperform doctors in diagnosis, but need safeguards to avoid overprescribing

by Yafei Si and Gang Chen,University of MelbourneCredit: AI-generated imageIf you've been to a medical appointment recently, you may have already interacted with AI. As you describe your symptoms
Public Health & Prevention December 28,2025
AI chatbots often outperform doctors in diagnosis, but need safeguards to avoid overprescribing

AI chatbots often outperform doctors in diagnosis, but need safeguards to avoid overprescribing

by Yafei Si and Gang Chen,University of MelbourneCredit: AI-generated imageIf you've been to a medical appointment recently, you may have already interacted with AI. As you describe your symptoms
Public Health & Prevention December 28,2025
'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer

'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer

by Ananya Sen,University of MichiganCredit: Jacob Dwyer, Justine Ross, Michigan MedicineLung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80
Hematology&Oncology December 28,2025
'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer

'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer

by Ananya Sen,University of MichiganCredit: Jacob Dwyer, Justine Ross, Michigan MedicineLung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80
Hematology&Oncology December 28,2025
FDA approves Waskyra for Wiskott-Aldrich syndrome

FDA approves Waskyra for Wiskott-Aldrich syndrome

by Lori SolomonThe U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).Waskyra is
Drug Discovery December 27,2025
FDA approves Waskyra for Wiskott-Aldrich syndrome

FDA approves Waskyra for Wiskott-Aldrich syndrome

by Lori SolomonThe U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).Waskyra is
Drug Discovery December 27,2025
FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme
Drug Discovery December 27,2025
FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme
Drug Discovery December 27,2025
Combined oral contraceptive use among people with migraine with aura persists, despite cautions

Combined oral contraceptive use among people with migraine with aura persists, despite cautions

byBoston UniversityCredit: Pixabay/CC0 Public DomainCurrent medical guidelines discourage the use of combined oral contraceptives (COCs) among people who experience migraine with aura—a type of migrai
Drug Discovery December 27,2025
Combined oral contraceptive use among people with migraine with aura persists, despite cautions

Combined oral contraceptive use among people with migraine with aura persists, despite cautions

byBoston UniversityCredit: Pixabay/CC0 Public DomainCurrent medical guidelines discourage the use of combined oral contraceptives (COCs) among people who experience migraine with aura—a type of migrai
Drug Discovery December 27,2025
Antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission

Antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission

byWalter and Eliza Hall Institute of Medical ResearchThese images show the malaria parasites before and after treatment. Without MK-7602, parasites (purple) invade red blood cells (blue) after two day
Drug Discovery December 27,2025
Antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission

Antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission

byWalter and Eliza Hall Institute of Medical ResearchThese images show the malaria parasites before and after treatment. Without MK-7602, parasites (purple) invade red blood cells (blue) after two day
Drug Discovery December 27,2025
More News
Week’s Top
Podcasts
... Can AI Catch What Doctors Miss? ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com